Contact
searchSearch
HMP Global

Evaluating the Risks and Benefits of Treatment Modalities for Hyperpigmentation

Popular Articles

Lawrence F. Eichenfield, MD, FAAD
Videos
Topical Medications in Atopic Dermatitis: Updates and Insights from Latest Guidelines
04/04/2024
Lawrence F. Eichenfield, MD, FAAD
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr...
04/04/2024
The Dermatologist
merola
Conference Coverage
Psoriasis and Psoriatic Arthritis Treatment: Interleukin Inhibitors
05/08/2024
Riya Gandhi, MA
During Spring Dermatology Week 2024, Dr Joseph Merola delivered a compelling presentation titled "Enhancing Outcomes for Psoriasis and Psoriatic Arthritis: An Emphasis on Interleukin Inhibitors."
During Spring Dermatology Week 2024, Dr Joseph Merola delivered a compelling presentation titled "Enhancing Outcomes for Psoriasis and Psoriatic Arthritis: An Emphasis on Interleukin Inhibitors."
During Spring Dermatology Week...
05/08/2024
The Dermatologist
alopecia
News
SiSaf’s Bio-Courier Technology Achieves Clinical Success for Topical Alopecia Areata Treatment
06/12/2024
Riya Gandhi, MA
SiSaf Ltd announced positive topline results from a phase II clinical trial of a licensee's topical treatment for mild to moderate alopecia areata (AA).
SiSaf Ltd announced positive topline results from a phase II clinical trial of a licensee's topical treatment for mild to moderate alopecia areata (AA).
SiSaf Ltd announced positive...
06/12/2024
The Dermatologist
Alopecia Areata, blad head
FDA Alerts
Deuruxolitinib FDA Approved for Severe Alopecia Areata in Adults
07/30/2024
Riya Gandhi, MA
The FDA has approved deuruxolitinib (LEQSELVI) 8 mg tablets for the treatment of adults with severe alopecia areata, a condition affecting approximately 300,000 individuals in the United States.
The FDA has approved deuruxolitinib (LEQSELVI) 8 mg tablets for the treatment of adults with severe alopecia areata, a condition affecting approximately 300,000 individuals in the United States.
The FDA has approved...
07/30/2024
The Dermatologist
psoriatic arthritis
News
Nutritional Effect on Lipoproteins Associated With Psoriatic Arthritis
09/11/2024
Jessica Garlewicz
This study aimed to evaluate the effects of a 12-week nutritional intervention on high-density lipoprotein and low-density lipoprotein cholesterol levels and their subfractions in patients with psoriatic arthritis.
This study aimed to evaluate the effects of a 12-week nutritional intervention on high-density lipoprotein and low-density lipoprotein cholesterol levels and their subfractions in patients with psoriatic arthritis.
This study aimed to evaluate the...
09/11/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use